COMMUNIQUÉS West-GlobeNewswire

Outcome of Infant Bacterial Therapeutics' rights issue
02/02/2018
Not for release, publication or distribution, directly or indirectly, in or into Australia, Hong Kong, Japan, Canada, Singapore, the United States or in any other jurisdiction where such distribution of this press [...]
Aquinox to Present at LEERINK Partners 7th Annual Global Healthcare Conference
02/02/2018
VANCOUVER, British Columbia, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“ Aquinox ”) (NASDAQ: AQXP ), a clinical-stage pharmaceutical company discovering and developing novel drug candidates to [...]
Athersys Enters Into New $100 Million Equity Facility with Aspire Capital
02/02/2018
Provides access to capital to support ongoing business and development objectives CLEVELAND, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX ) and Aspire Capital Fund, LLC (“Aspire Capital”) announced [...]
OraSure Technologies Appoints Aradhana Sarin, M.D. to Board of Directors
02/02/2018
BETHLEHEM, Pa., Feb. 02, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR ), a leader in point of care diagnostic tests and specimen collection devices, today announced the appointment of Dr. Aradhana [...]
OpGen Announces Pricing of $12 Million Upsized Public Offering
02/02/2018
GAITHERSBURG, Md., Feb. 02, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN ) announces the pricing of a public offering of an aggregate of 3,692,307 units. Each unit is comprised of one share of common stock (or [...]
Announcement by Irina Maligina and Nika Saveljeva, Daughters of Late Valerijs Maligins
02/02/2018
Olaine, 2018-02-02 08:57 CET (GLOBE NEWSWIRE) -- In relation to the sudden passing away of our father Valerijs Maligins and his will to share his inheritance equally among all three of his daughters, we would like to [...]
Solon Eiendom ASA : Primary insider notification
02/02/2018
(Oslo, Norway, February 01, 2018) Solon Eiendom ASA Board Member Tore Aksel Voldberg (through his wholly owned company Skøien AS) has today bought 45.000 shares in Solon Eiendom ASA at a price of NOK 21.8681. Following [...]
Solon Eiendom ASA : Primary insider notification
02/02/2018
(Oslo, Norway, February 01, 2018) Solon Eiendom ASA Chairman of the Board Simen Thorsen (through his wholly owned company Hortulan AS) has today bought 45,000 shares in Solon Eiendom ASA at a price of NOK 21.8681 per [...]
Solon Eiendom ASA : Primary insider notification
02/02/2018
(Oslo, Norway, February 01, 2018) Solon Eiendom ASA Board Member Edvin Austbø (through his wholly owned company Alden AS) has today bought 45,000 shares in Solon Eiendom ASA at a price of NOK 21.8681 per share. [...]
Solon Eiendom ASA : Primary insider notification
02/02/2018
(Oslo, Norway, February 01, 2018) Solon Eiendom ASA CEO Andreas Martinussen (through his wholly owned company John Galt AS) has today bought 50,000 shares in Solon Eiendom ASA at a price of NOK 21.8681 per share. [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
02/02/2018
REGULATED INFORMATION GHENT, Belgium, 2 February 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
Van Leeuwenhoeck Issues Equity Research Note Highlighting Value of Recent Indivior Strategic Partnership on GABAB PAM
02/02/2018
Geneva, Switzerland, 2 February 2018 - Addex Therapeutics (SIX: ADXN) announced today that the independent life science research company Van Leeuwenhoeck has issued an equity research note highlighting the value of the [...]
Targovax ASA: Exercise price of options
02/02/2018
With reference to the Stock exchange notification issued 1 February 2018 regarding options to employees: The exercise price of the granted options is NOK 17.17. The exercise price is equal to the volume weighted average [...]
INSYS Therapeutics Addresses New York Attorney General’s Complaint
02/02/2018
PHOENIX, Feb. 01, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY ), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today released the [...]
Kane Biotech Provides Additional Information Regarding Engagement of Investor Relations Counsel
02/02/2018
WINNIPEG, Manitoba, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V: KNE ) (OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) is pleased to announce additional information regarding its engagement of Edison [...]
MedMira Announces AGM Results and Stock Option Grant
02/02/2018
HALIFAX, Nova Scotia, Feb. 01, 2018 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV:MIR) held its 2018 Annual General Meeting of Shareholders on January 31, 2018 in Halifax, Nova Scotia. Incumbent Directors Mr. Hermes [...]
Revocation of CTO and Reinstatement to Trade
02/02/2018
BROSSARD, Québec, Feb. 01, 2018 (GLOBE NEWSWIRE) -- ZoomMed Inc. (TSX Venture Exchange:ZMD) (“ZoomMed”) is pleased to announce that the TSX Venture Exchange will be issuing a bulletin to reinstate trading in ZoomMed’s [...]
Levée de l’interdiction d’opérations et reprise de la négociation
02/02/2018
BROSSARD, Québec, 01 févr. 2018 (GLOBE NEWSWIRE) -- ZoomMed Inc. (Bourse de croissance TSX:ZMD) (“ZoomMed”) est heureuse d’annoncer que la Bourse de croissance TSX émettra un bulletin visant la reprise de la négociation [...]
MediciNova Announces MN-166 (ibudilast) Demonstrated a 26% Reduction in Confirmed Disability Progression in the SPRINT-MS Phase 2b Trial in Progressive MS: Potential Best-in-Disease Drug
02/02/2018
LA JOLLA, Calif., Feb. 01, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875 [...]

Pages